RESINIFERATOXIN-INDUCED LOSS OF VANILLOID RECEPTORS IS REVERSIBLE IN THE URINARY-BLADDER BUT NOT IN THE SPINAL-CORD OF THE RAT

被引:27
作者
GOSO, C [1 ]
PIOVACARI, G [1 ]
SZALLASI, A [1 ]
机构
[1] MENARINI SUD,DEPT PHARMACOL,ROME,ITALY
关键词
VANILLOID RECEPTOR LOSS; RESINIFERATOXIN; DESENSITIZATION; NEUROTOXICITY; SPINAL CORD; URINARY BLADDER;
D O I
10.1016/0304-3940(93)90594-B
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Resiniferatoxin (RTX) induced a dose-dependent loss of vanilloid receptors (specific [H-3]RTX-binding sites) in tissues containing peripheral (urinary bladder) and central (spinal cord) endings of capsaicin-sensitive neurons. This receptor loss in the spinal cord was entirely due to a reduction in the B(max). When examined 24 h after s.c. RTX treatment, receptor loss required somewhat less RTX in the urinary bladder (ED50 = 10 mug/kg) than in the spinal cord (ED50 = 50 mug/kg), whereas the loss of the xylene-induced neurogenic inflammatory response in the bladder displayed an approximate ED50 of 5 mug/kg. In the bladder of rats pretreated with 30 mug/kg RTX, both receptor binding and neurogenic inflammatory response recovered almost completely within 2 month after treatment. In the bladder of rats that received a 10-fold higher RTX dose, a 50% recovery of binding and a 70% recovery of the Evans' blue extravasation response were found. By contrast, no recovery of specific [H-3]RTX binding to spinal cord membranes was observed at either dose. These findings suggest that vanilloid receptor loss after RTX treatment can be either reversible (desensitization) or irreversible (most likely reflecting neurotoxicity), and that peripheral and central terminals of capsaicin-sensitive neurons have a differential sensitivity to these long-term vanilloid actions.
引用
收藏
页码:197 / 200
页数:4
相关论文
共 19 条
[1]  
BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330
[2]   CAPSAZEPINE - A COMPETITIVE ANTAGONIST OF THE SENSORY NEURON EXCITANT CAPSAICIN [J].
BEVAN, S ;
HOTHI, S ;
HUGHES, G ;
JAMES, IF ;
RANG, HP ;
SHAH, K ;
WALPOLE, CSJ ;
YEATS, JC .
BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (02) :544-552
[3]   NEUROPHARMACOLOGICAL MECHANISMS OF CAPSAICIN AND RELATED SUBSTANCES [J].
DRAY, A .
BIOCHEMICAL PHARMACOLOGY, 1992, 44 (04) :611-615
[4]  
HOLZER P, 1991, PHARMACOL REV, V43, P143
[6]   SELECTIVE DEGENERATION BY CAPSAICIN OF A SUBPOPULATION OF PRIMARY SENSORY NEURONS IN THE ADULT-RAT [J].
JANCSO, G ;
KIRALY, E ;
JOO, F ;
SUCH, G ;
NAGY, A .
NEUROSCIENCE LETTERS, 1985, 59 (02) :209-214
[7]  
JANCSO N, 1968, PHARM PAIN, V9, P33
[8]  
Janeso G, 1992, NEUROPEPTIDES, V22, P34
[9]   THERAPEUTIC POTENTIAL OF CAPSAICIN-LIKE MOLECULES - STUDIES IN ANIMALS AND HUMANS [J].
MAGGI, CA .
LIFE SCIENCES, 1992, 51 (23) :1777-1781
[10]   THE SENSORY-EFFERENT FUNCTION OF CAPSAICIN-SENSITIVE SENSORY NEURONS [J].
MAGGI, CA ;
MELI, A .
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1988, 19 (01) :1-43